Followers | 680 |
Posts | 141062 |
Boards Moderated | 36 |
Alias Born | 03/10/2004 |
Friday, September 06, 2019 4:07:51 PM
By: Schaeffer's Investment Research | September 5, 2019
• After a judge approved the Aetna merger, the drugstore stock surged
• CVS call traders banked a huge profit in just one trading day
Subscribers to Schaeffer's Weekly Options Countdown options recommendation service just scored a major profit on the CVS Health Corp (NYSE:CVS) weekly 9/6 59.50-strike call. Below, we'll explain why we expected a leg up for CVS shares, and how the winning options trade unfolded.
When we recommended the trade to subscribers on Sunday, Sept. 1, CVS had made a bullish U-turn after basing for five months. The shares were trading north of their 200-day moving average -- a former ceiling for the stock -- and had found potential support at their 20-day trendline and the round-number $60 level, too. Off the charts, CVS reported strong earnings in August, and hiked its full-year earnings forecast.
The stock also sported a Schaeffer's Volatility Index (SVI) of 23%, which registered in the low 12th percentile of its annual range. This meant that near-term options premiums were pricing in unusually low volatility expectations for the pharmacy stock. Likewise, CVS had a Schaeffer's Volatility Scorecard (SVS) of 84 (out of a possible 100), meaning the security had handily exceeded options traders' volatility expectations during the past year.
When we entered the trade on Tuesday, Sept. 3, CVS closed lower on the day, but managed to hold above critical support at its 200-day moving average despite a broadly bearish session for the U.S. equities market. Then, on Wednesday, Sept. 4, the stock gapped higher out of the gate on overnight news that a federal judge cleared some lingering antitrust red tape from last year's purchase of insurance name Aetna by CVS.
The well-received regulatory news sent CVS shares popping right out of the gate on Wednesday, and our recommended weekly 9/6 59.50-strike call gained in value as well. After trading at a volume-weighted average price (VWAP) of $1.12 on Tuesday, the contract's VWAP shot up to $2.05 by the end of the day Wednesday.
As a result, our trade achieved its target profit of 100% right after the trading session started on Wednesday -- just about 24 hours after the trade was initiated, and during a period of time where CVS stock rose only 1.2%, from Tuesday's opening price to Wednesday's opening gap.
Read Full Story »»»
• DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Your Due Dilegence is a must!
• DiscoverGold
Recent CVS News
- CVS Health, Starbucks, Shares Weaker; Pinterest Soars • IH Market News • 05/01/2024 01:12:05 PM
- CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE • PR Newswire (US) • 05/01/2024 10:30:00 AM
- Philips Stocks Soar 47% Following US Deal, Tesla Bolsters Presence in China, and More News • IH Market News • 04/29/2024 11:11:24 AM
- CVS Health opens new workforce development and community resource center in Baton Rouge • PR Newswire (US) • 04/25/2024 01:00:00 PM
- CVS Health invests $19.2 million in affordable housing in Arvada, Colorado • PR Newswire (US) • 04/24/2024 01:00:00 PM
- Baum Family Investments Embarks on Triple Net Lease Strategy with $250 Million Acquisition Goal • PR Newswire (US) • 04/23/2024 08:10:00 PM
- Aetna Better Health of Michigan recommended for CHCP contract • PR Newswire (US) • 04/09/2024 04:00:00 PM
- CVS Health® expands pharmacy tuition assistance and scholarship programs • PR Newswire (US) • 04/03/2024 12:00:00 PM
- CVS Health to hold first quarter 2024 earnings conference call • PR Newswire (US) • 04/01/2024 01:00:00 PM
- CVS Health® invests more than $3M in organizations improving health outcomes in Phoenix • PR Newswire (US) • 03/27/2024 06:00:00 PM
- CVS Health announces quarterly dividend • PR Newswire (US) • 03/21/2024 02:55:00 PM
- AM Best Affirms Credit Ratings of Most of CVS Health Corporation’s Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna • Business Wire • 03/13/2024 09:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:09:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:21:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:20:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:18:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 09:37:48 PM
- CVS Health invests nearly $35 million in affordable housing in Hawai'i • PR Newswire (US) • 02/22/2024 01:45:00 AM
- CVS Health to participate at the 45nd Annual Raymond James Institutional Investors Conference • PR Newswire (US) • 02/21/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:46:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 09:12:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:15:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:14:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:13:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:12:23 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM